IL18 and colorectal carcinoma: In addition, some research groups have reported that interleukin 1β (IL-1β) and interleukin 18 (IL-18) can prevent the occurrence and progress of CRC, which suggests that the inflammatory cytokines can have both detrimental and beneficial effects depending on the context [80–82].